← Top stories
Policy▼ Bearish for PB Fintech
PB Fintech forced to rethink business plan as India insurance commissions cap comes as a major shocker
The brief
- Proposed insurance commission caps could severely impact PB Fintech’s revenue
- Commission caps threaten revenue at PB Fintech, operator of Policybazaar
| Stock | Traded | That day | vs Nifty | Volume | Since |
|---|---|---|---|---|---|
| POLICYBZR | Fri, 25 Sept | −3.4% | −3.7% | 16× | −3.4% · Nifty +0.3% |
✓ Classifier read this as negative; POLICYBZR fell 3.7% against the Nifty on the day it traded.
- Should one buy the PB Fintech dip? Bernstein sees 91% upside but here's what others said
- Stock Picks Today: TCS, SBI, BPCL, Lenskart, PB Fintech And More On Brokerages' Radar
- PB Health’s hospital expansion plans on track: PB Fintech Chairman and Group CEO
- F&O Talk: 23,270 is a key Nifty hurdle; Sudeep Shah picks 5 stocks, discusses PB Fintech, Turtlemint strategy
- What Policybazaar’s Rs 34,000 crore wipeout reveals about the ills of insurance
IRDAI's proposed insurance distribution reforms
IRDAI proposed phased cuts to insurers’ expense limits, commission caps and a ban on compulsory insurance bundling with loans. The proposals prompted debate over premiums, mis-selling and distributor payouts, while reports highlighted possible earnings risks for PB Fintech.
Thursday, 24 September
- PB Fintech forced to rethink business plan as India insurance commissions cap comes as a major shocker